---
document_datetime: 2025-10-02 11:30:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/brukinsa-epar-all-authorised-presentations_en.pdf
document_name: brukinsa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7118497
conversion_datetime: 2025-12-15 01:04:37.314147
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size    |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|--------------|
| EU/1/21/1576/001 | Brukinsa          | 80 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 120 capsules |
| EU/1/21/1576/002 | Brukinsa          | 160 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE)         | 60 tablets   |